CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENTConvertible Promissory Note and Warrant Purchase Agreement • September 10th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations • California
THIS CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT is made as of July 9, 2014, by and among DW Odell Company, LLC, a California limited liability company (the “Investor”) and VG Life Sciences Inc. (the "Company" or “VGLS”).
CONSULTING AGREEMENTConsulting Agreement • September 10th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations • California
THIS CONSULTING AGREEMENT (“the Agreement”) is made and entered into by and between VG LIFESCIENCES INC., a Delaware corporation (the “Client”), and Richard Tobin (“Consultant”) effective the ________________.
FIRST AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENTConvertible Promissory Note and Warrant Purchase Agreement • September 10th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations
This First Amendment to the Convertible Promissory Note and Warrant Purchase Agreement (“Agreement”), dated as of July 9, 2014, between VG Life Sciences Inc. (the “Company”) and Wild Harp Holdings, LLC (“Investor”) is made and entered effective as of the August 14, 2014.
FIRST AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENTConvertible Promissory Note and Warrant Purchase Agreement • September 10th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations
This First Amendment to the Convertible Promissory Note and Warrant Purchase Agreement (“Agreement”), dated as of July 9, 2014, between VG Life Sciences Inc. (the “Company”) and DW Odell Company, LLC (“Investor”) is made and entered effective as of the August 14, 2014.
